PATENT CLAIM ANALYSIS

Application Number: 15769201
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "211060"]

Abstract:
The present invention provides a heterocyclic compound having an RIP1 kinase inhibitory action, which is useful for the prophylaxis or treatment of Gaucher's disease, Niemann-Pick disease, inflammatory bowel disease, multiple sclerosis, chronic kidney disease, acute kidney injury, acute hepatic failure, autoimmune hepatitis, hepatitis B, hepatitis C, alcohol steatohepatitis, non-alcohol steatohepatitis and the like. The present invention relates to a compound represented by the following formula (I): wherein each symbol is as defined in the specification, or a salt thereof.

Claim (Index 6):
The compound or salt according to  claim 1 , wherein\n Ring A is an optionally further substituted benzene, R 1  is a C 1-6  alkyl group, X is an oxygen atom, Ring D is an optionally further substituted piperidine, Ring B is an optionally further substituted pyrazole, L is an optionally substituted methylene, and Ring C is an optionally further substituted benzene.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 91.0
- Lexical Diversity: 1.48485
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14781665', '14404126', '14379343', '15459141', '15506380']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7628149370487632
- 35 USC 102 Novelty (BERT): 0.5108758903022281
- Combined Prediction Score: 0.7376210323741097
- Mean Citation Score: 278.609828
- Max Citation Score: 288.73636
- Similarity Product: 247.9541004424668

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test